<scp>OS</scp>‐01 Peptide Topical Formulation Improves Skin Barrier Function and Reduces Systemic Inflammation Markers: A Pilot 12‐Week Clinical Trial
The study suggests that the OS-01 formulation can impact skin health by improving the skin barrier function, potentially influencing systemic inflammation and biological age. In conclusion, the study supports that targeting skin health may contribute to better longevity outcomes, underscoring the skin's pivotal role in systemic aging and supporting an integrated approach to health management.
Authors
- Nathaniel H. O. Harder (ORCID: https://orcid.org/0000-0002-5498-3570)
- Mariana Boroni
- Alessandra Zonari (ORCID: https://orcid.org/0000-0002-0093-356X)
- Chung Sang Tse (ORCID: https://orcid.org/0000-0002-8847-4539)
- Lear E. Brace (ORCID: https://orcid.org/0000-0001-6961-9758)
- Juliana Lott Carvalho (ORCID: https://orcid.org/0000-0002-1423-0523)
- Claire Harker
- Carolina R. Oliveira
- Adam B. Aronson
- Luiza Brunelli Buhrer
Institutions
- Universidade de Brasília (BR)
- Universidade Católica de Brasília (BR)
- Instituto Nacional de Câncer - INCA (BR)
Publication Details
- Journal
- Journal of Cosmetic Dermatology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1111/jocd.70169
- Citations
- 2
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.01